Haider Inam (@HaiderInam) header
Haider Inam (@HaiderInam) profile picture

Research Scientist at the Broad Institute of MIT and Harvard

Cambridge, MA
Joined February 2010
Acquired drug resistance is a major barrier to curative cancer therapies. I'm excited to share our new study describing a gene therapy platform that proactively targets resistance and enables durable remissions. Out now in @NatureBiotech 🧵below
Programming tumor evolution with selection gene drives to proactively combat drug resistance go.nature.com/4bLLeFb
4
5
16
7,062
What an honor to talk at the Sanger Institute!
Haider Inam on quantifying resistance to targeted anticancer therapies at scale with duplex sequencing #VariantEffect23
1
6
395
So honored!
This Post is from an account that no longer exists. Learn more
3
322
Haider Inam retweeted
Haider Inam on quantifying resistance to targeted anticancer therapies at scale with duplex sequencing #VariantEffect23
4
1
15
2,374
Next up is @ScottLeighow from @JustinPritcha19 lab presenting: Design and construction of evolutionary-guided “selection gene drive” therapy #AACRevol22 Very cool talk!
Unprotected African health workers die as rich countries buy up COVID-19 vaccines sciencemag.org/news/2021/02/…
Check out our lab’s most recent publication!
Engineers model mutations causing drug resistance | Penn State University news.psu.edu/story/612719/20…
1
Haider Inam retweeted
Pairwise tests for conditional selection use evolutionary logic to predict intrinsic drug resistance in ALK alterations dlvr.it/R85PZr
1
1
@UVADeanGroves Thanks a lot for coming out to MSA's candlelight vigil event for Peshawar. You shared kind words and we really appreciate it!
1
4